- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NPPA Fixes Ceiling Price of ringer lactate injection
![NPPA Fixes Ceiling Price of ringer lactate injection NPPA Fixes Ceiling Price of ringer lactate injection](https://medicaldialogues.in/h-upload/2022/10/19/750x450_188505-nppa-new.webp)
New Delhi: Through a recent notification, the drug price regulator, National Pharmaceutical Pricing Authority (NPPA) has revised and fixed the ceiling price of ringer lactate injection of 4 different strengths.
The ceiling price for a 100 ml ringer lactate injection has been set at Rs. 29.90, and the ceiling price for a 250 ml ringer lactate injection has been set at Rs. 50.99.
Additionally, the ceiling prices for the ringer lactate injection 500ml and 1000ml have been set at Rs. 64.96 and Rs. 114.19, respectively.
In accordance with the recent notification, the manufacturers are Albert David, Aculife Healthcare, B. Braun Medical (India), Fresenius Kabi India,Ostuka Pharmaceuticals, Denis Chem lab, Amanta Healthcare, Shree Krishna Keshav Laboratories, AxaParenterals, Shree Krishna Keshav Laboratories AxaParenterals, Rusoma Laboratories, R. K. Laboratories, RealcadeLifesciencePvt, Abaris Healthcare Pvt, Higgs Healthcare, Rusoma Laboratories, Puerto Life Sciences Private Limited, Sachin Parenteral Pv.
"Ceiling Price" refers to a price fixed by the Government for Scheduled Formulations in accordance with the provisions of the drugs (prices control) order, 2013. The ceiling Price is the Maximum Price to Retailer (excluding Taxes, if any) for the given product.
Scheduled formulation means any formulation, included in the First Schedule whether referred to by generic versions or brand names (mainly products covered under the National List of Essential Medicines are Scheduled Formulation). In other words, all medicines that are covered in the National List of Essential Medicine, which are notified in Schedule 1, by the Govt. are scheduled formulation.
The notice declared that in exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016, S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. No. 1501(E) dated 30.03.2022 andS.O. 4592(E) dated 29.09.2022, in so far as it relates toformulation packs mentioned in the Table A below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index(WPI) of 2022 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of Goods and Services Tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof:
Price Revision as per Annual Wholesale Price Index (WPI) @ 12.1218% increase.
Sl No | Medicines | Dosage Form and Strength | Unit | Ceiling price (w.e.f.01.04.2023 with WPI @ 12.1218%) |
(1) | (2) | (3) | (4) | (5) |
1 | Ringer lactate | Injection100 ml | Each 100 ml pack having special features | 29.90 |
2 | Ringer lactate | Injection 250 ml | Each 250 ml pack having special features | 50.99 |
3 | Ringer lactate | Injection 500 ml | Each 500 ml pack having special features | 64.96 |
4 | Ringer lactate | Injection 1000 ml | Each 1000 ml pack having special features | 114.19 |
TABLE ‘B’
Sl. No. | Name of Manufacturer |
(1) | (2) |
1 | M/s Albert David Ltd. |
2 | M/s Aculife Healthcare Pvt. Ltd. |
3 | M/s B. Braun Medical (India) Pvt. Ltd. |
4 | M/s Fresenius Kabi India Pvt. Ltd. |
5 | M/s Ostuka Pharmaceuticals India Pvt. Ltd. |
6 | M/s Denis Chem lab Ltd. |
7 | M/s Amanta Healthcare Ltd. |
8 | M/s Shree Krishna Keshav Laboratories Ltd. |
9 | M/s AxaParenterals Ltd. |
10 | M/s Rusoma Laboratories Pvt. Ltd. |
11 | M/s R. K. Laboratories Pvt. Ltd. |
12 | M/s RealcadeLifesciencePvt. Ltd. |
13 | M/s Abaris Healthcare Pvt. Ltd (Note (b) below) |
14 | M/s Higgs Healthcare (Note (c) below) |
15 | M/s Rusoma Laboratories Pvt. Ltd. (Eurohead Bottles with Brand name “Dewdrip”) (Note (b) below) |
16 | M/s Puerto life Sciences Private Limited (Note (d) below) |
17 | M/s Sachin Parenteral Pvt. Ltd. (Brand name “SAFE PORT”) (Note (d) below) |
Notes:
Also Read: Akums gets CDSCO Panel nod for Phase III CT of FDC Moxifloxacin, Nepafenac ophthalmic solution
Doctor of Pharmacy
Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.